Hepatitis C: are there any options for non-responders?

Rev Esp Enferm Dig. 2005 May;97(5):299-305. doi: 10.4321/s1130-01082005000500001.
[Article in English, Spanish]
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Amantadine / therapeutic use
  • Antiviral Agents / therapeutic use
  • Drug Therapy, Combination
  • Genotype
  • Hepacivirus / genetics
  • Hepatitis C / drug therapy*
  • Hepatitis C / virology
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use
  • Polyethylene Glycols
  • Recombinant Proteins
  • Ribavirin / therapeutic use
  • Treatment Failure

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • Ribavirin
  • Amantadine
  • peginterferon alfa-2b